MCRB
Seres Therapeutics Inc

9,292
Loading...
Loading...
News
all
press releases
Seres Therapeutics (MCRB)'s Technical Outlook is Bright After Key Golden Cross
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
Zacks·11d ago
News Placeholder
More News
News Placeholder
Wall Street Analysts Believe Seres Therapeutics (MCRB) Could Rally 713.09%: Here's is How to Trade
Zacks·4mo ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, MCRB, LLAP on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, MCRB, LLAP on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, MCRB, LLAP on Behalf of Shareholders...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCRB, PALT, MRO on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCRB, PALT, MRO on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCRB, PALT, MRO on Behalf of Shareholders...
PR Newswire·1y ago
News Placeholder
MCRB Investigation Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Seres Therapeutics, Inc. Assets Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether Seres Therapeutics, Inc.s (NASDAQ: MCRB) sale of its VOWST microbiome therapeutic business to Socit des Produits Nestl S.A is...
Business Wire·1y ago
News Placeholder
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer Flagship Pioneering...
PR Newswire·1y ago
News Placeholder
Nestl Health Science agrees to acquire global rights to VOWST, product it launched in June 2023
Nestl Health Science agrees to acquire global rights to VOWST, product it launched in June 2023 Nestl Health Science agrees to acquire global rights to VOWST, product it launched in June 2023 PR...
PR Newswire·1y ago
News Placeholder
Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management
Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management Flagship Pioneering and Metaphore...
PR Newswire·1y ago
News Placeholder
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported first quarter 2024 financial results and provided business updates. 'With a broad indication and...
Business Wire·1y ago
News Placeholder
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading microbiome therapeutics company, today announced that on May 1, 2024, the Compensation and Talent Committee of Seres board of...
Business Wire·1y ago

Latest MCRB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.